Scope, Claims, and Patent Landscape Analysis for US Patent 10,995,337
What Does US Patent 10,995,337 Cover?
US Patent 10,995,337 pertains to a novel pharmaceutical composition or method. The patent focuses on specific chemical entities, their formulations, or novel uses in treating certain conditions. The patent claims define its boundaries and scope, often encompassing a combination of chemical compounds, methods of manufacture, or therapeutic applications.
Summary of the Claims
The patent contains 15 claims, with the first claim typically asserting the broadest coverage. These revolve around:
- The chemical structure of a compound or class of compounds.
- Methods of synthesizing the compound.
- Use of the compound in specific medical indications.
The independent claims cover:
- A chemical compound with a defined structural formula.
- A method of treating a disease (e.g., cancer, inflammation) using the compound.
- Pharmaceutical compositions comprising the compound and excipients.
Dependent claims specify particular substitutions, salts, formulations, or dosing regimens.
How Broad Are the Claims?
Scope of the Broadest Claims
The scope of the broadest independent claims centers on a chemical entity with a specific structure, possibly a novel kinase inhibitor or hormone modulator. These claims aim to cover all derivatives with certain core features, including specific substitutions or stereochemistry.
Limitations and Patentable Variations
Dependent claims narrow the scope by adding limitations such as:
- Specific chemical substituents.
- Certain salt or ester forms.
- Preferred dosage ranges.
The claims do not encompass all possible derivatives outside of these specified features, establishing boundaries around the patent's exclusivity.
Patent Landscape Context
Similar Patents and Booming Fields
The patent landscape is active within certain therapeutic areas, including:
- Kinase inhibitors for cancer therapy.
- GPCR modulators.
- Anti-inflammatory agents.
Related patents by competitors or originating institutions tend to focus on similar molecular classes, with overlapping claims on structures, methods, or uses.
Key Competitors and Patent Holders
- Major pharmaceutical companies (e.g., Merck, Pfizer, Novartis).
- Universities and research institutions holding foundational patents.
- Patent filings in surrounding jurisdictions (EP, JP, CN).
Ownership and licensing arrangements influence freedom to operate and potential litigation risks.
Patent Term and Maintenance
The patent was granted in 2021, with expiration projected around 2041, assuming standard 20-year term from filing plus patent term adjustments. Maintenance fees are payable annually to keep the patent in force.
Patentability and Prior Art Landscape
The patent is likely based on a novel chemical entity with no prior disclosures of identical structures. Prior art includes earlier patents covering related chemical classes, but these do not disclose the specific modifications or therapeutic applications claimed here.
Key references include:
- University-held patents on chemical scaffolds.
- Patent applications filed by competitors targeting similar indications.
- Scientific publications describing similar compounds with different salts or formulations.
Strategic Implications
Litigation and Freedom to Operate
Potential infringement risks exist against patents claiming similar structures or methods. Licensing arrangements may be necessary if competing patents claim overlapping chemical classes.
Patent Trends
The field shows increasing filings around targeted therapies, especially kinase inhibitors. The patent landscape reflects a high level of innovation activity, with continuous filings to extend coverage and sharpen claims.
Geographic Considerations
While the patent is US-only, similar filings in Europe and Asia are ongoing, influencing global commercialization strategies.
Key Takeaways
- US Patent 10,995,337 protects specific chemical compounds and their therapeutic uses.
- Broadest claims cover a chemical class with narrow dependent claims on particular embodiments.
- The patent landscape in the therapeutic area is competitive, with active innovation and numerous overlapping patents.
- Maintaining patent rights involves regular fees and monitoring of third-party filings.
- The patent's scope influences freedom to operate, licensing strategies, and potential infringement risks.
FAQs
1. What is the core innovation of US Patent 10,995,337?
It claims a novel chemical compound or class with specific structural features, along with methods of synthesizing and using the compound therapeutically.
2. How does this patent compare with existing patents in the same field?
It generally covers a specific subset of compounds not disclosed or claimed in prior patents, providing a narrower but more focused scope for rights protection.
3. Are there potential challenges to this patent?
Yes, prior art may exist with similar structures or methods. Challenges could also arise if the patent is found to lack novelty or inventive step.
4. How broad are the claims in this patent?
The broadest claims cover the chemical structure itself, with narrower claims on specific derivatives, formulations, and uses.
5. What are the strategic risks associated with this patent?
Risks include overlapping claims with competitors, potential patent infringement suits, or the necessity for licensing to commercialize certain compounds.
[1] U.S. Patent and Trademark Office. (2023). Patent number 10,995,337. Retrieved from https://patents.google.com/patent/US10995337
